Makale detayı · 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
YÖKSİS
OpenAlex
Açık erişim · bronze
SJR Q1
JCR Q1
Atıf 48
Üst %10
Yüzdelik 91.4%
FWCI 2.74
- Yıl
- 2021
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı Nature Immunology
- Katalog eşleşmesi (ISSN) Nature Immunology
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
48 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 15 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity. 2023
- The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity 2023
- Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency 2023
- The middle east and north africa diagnosis and management guidelines for inborn errors of immunity 2022
- The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity 2022
- The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity 2022
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies 2022
- The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity 2022
- The Middle East and North Africa Diagnosis and Management Guidelines for Inborn Errors of Immunity 2022
- Omalizumab may facilitate drug desensitization in patients failing standard protocols 2022